This Tiny Brain Cluster Controls Your Appetite
16:41 - June 06, 2025

This Tiny Brain Cluster Controls Your Appetite

TEHRAN (ANA)- Scientists at the Max Planck Institute for Metabolism Research have made an exciting breakthrough and they’ve identified a tiny group of nerve cells in the brain that plays a major role in controlling appetite and weight.
News ID : 9106

This could open the door to more targeted and effective treatments for obesity, the journal Cell reported.

Researchers found a small, specialized group of nerve cells in the hypothalamus that influence hunger and weight gain.

These cells respond to leptin, a natural hormone that helps suppress appetite.

The discovery could lead to new therapies that are more precise and have fewer side effects than current medications.

In a fascinating new study, researchers have identified a small group of nerve cells in the brains of mice that can trigger increased eating and lead to obesity. These nerve cells, known as PNOC/NPY neurons, are also found in the human brain. Using cutting-edge genetic and molecular tools, scientists were able to study these neurons at the single-cell level and sort them into distinct groups. Among them, just one specific cluster appears to be responsible for the overeating behavior.

The discovery became even more intriguing when researchers explored how these cells interact with leptin, a hormone made by body fat that helps suppress appetite. They found that about 10% of the PNOC neurons have receptors for leptin. When these receptors were removed in mice, the animals ate significantly more and gained weight.

“It was surprising that such a small group of nerve cells specifically leads to obesity,” explains Marie Holm Solheim, first author of the study.

The researchers plan to continue studying these nerve cells to identify additional specific targets for potential drugs and to make them amenable to pharmacological intervention.

“We hope that drugs that act on this specialized group of nerve cells will offer promising alternative therapies,” says Jens Brüning, head of the study. “However, there is still a long way to go before these can be used.”

4155/v

 

Send comment